High ADA activity might give a selective advantage to the cancer cells producing a high amount of hypoxanthine, a substrate for the salvage pathway by the activity of hypoxanthine guanine phosphoribosyl transferase (HGPRT).18 Therefore, the inhibition of adenosine degradation deserves a special attention in the cancer therapy. The gene discussed is ADA; the disease is cancer.